New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
10:01 EDTZTS, ARP, PTEN, NOV, HP, SFLY, OIS, NBR, EW, SPN, PDS, OII, NCS, NILE, SSHOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Blue Nile (NILE) initiated with an Outperform at Wells Fargo... Edwards Lifesciences (EW) initiated with a Buy at Janney Capital... Helmerich & Payne (HP) initiated with a Neutral at Credit Suisse... NCI Building Systems (NCS) initiated with a Buy at BB&T... Nabors Industries (NBR) initiated with an Underperform at Credit Suisse... National Oilwell (NOV) initiated with a Neutral at Credit Suisse... Oceaneering (OII) initiated with a Neutral at Credit Suisse... Oil States (OIS) initiated with an Outperform at Credit Suisse... Patterson-UTI Energy (PTEN) initiated with a Neutral at Credit Suisse... Precision Drilling (PDS) initiated with a Neutral at Credit Suisse... Shutterfly (SFLY) initiated with a Market Perform at Wells Fargo... Sunshine Heart (SSH) initiated with an Overweight at Piper Jaffray... Zoetis (ZTS) initiated with a Buy at ISI Group... Superior Energy (SPN) initiated with an Outperform at Credit Suisse... Atlas Resource Partners (ARP) initiated with a Neutral at Citigroup.
News For NILE;EW;HP;NCS;NBR;NOV;OII;OIS;PTEN;PDS;SFLY;SSH;SPN;ZTS;ARP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
December 11, 2014
10:13 EDTZTSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:12 EDTZTSZoetis initiated with a Market Perform at Cowen
Subscribe for More Information
07:03 EDTSPNSuperior Energy authorizes new share repurchase program of up to $500M
Subscribe for More Information
December 10, 2014
10:33 EDTARPOptions with increasing implied volatility
Subscribe for More Information
08:01 EDTSPNCapital One to hold a conference
Subscribe for More Information
December 9, 2014
16:27 EDTNCSNCI Building Systems reports Q4 EPS 19c, consensus 17c
Subscribe for More Information
15:18 EDTNCSNotable companies reporting after market close
Subscribe for More Information
11:19 EDTZTSSanofi reportedly ready to make acquisitions in animal medicine, Bloomberg says
Subscribe for More Information
10:23 EDTOII, NBROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:31 EDTZTSZoetis drops after report of Valeant abandoning growth by acquisitions strategy
Subscribe for More Information
08:07 EDTEWEdwards Lifesciences price target raised to $155 from $135 at JMP Securities
Subscribe for More Information
07:36 EDTEWEdwards Lifesciences TAVI growth reinforces bullish stance, says Canaccord
Subscribe for More Information
07:07 EDTEWEdwards price target raised to $151-$152 from $135-$140 at Wells Fargo
Wells Fargo increased its price target on Edwards Lifesciences as the firm believes that the company's roughly in-line 2015 guidance announced yesterday is conservative.The firm also notes that the company raised its long-term TAVR market assumption to over $3B in 2019. The firm keeps an Outperform rating on the shares.
05:51 EDTNBRNabors Industries downgraded to Hold from Buy at Jefferies
Subscribe for More Information
05:50 EDTOIIOceaneering downgraded to Hold from Buy at Jefferies
Subscribe for More Information
December 8, 2014
08:16 EDTEWEdwards Lifesciences announces investments in CardioKinetix
Edwards made a structured investment in CardioKinetix, a privately held medical device company pioneering a catheter-based treatment for heart failure. This transaction increases Edwards' existing minority interest in CardioKinetix and provides an option to purchase the remaining outstanding shares for a future payment, plus additional milestone payments based on future regulatory and reimbursement approvals. In the second investment, the company acquired intellectual property that broadens its transcatheter mitral valve development efforts. Additional details of both investments were not disclosed.
08:15 EDTEWEdwards Lifesciences sees FY15 EPS $3.90-$4.10, consensus $3.96
Subscribe for More Information
08:12 EDTEWEdwards Lifesciences backs FY14 EPS $3.33-$3.39, consensus $3.39
Subscribe for More Information
06:05 EDTEWEdwards Lifesciences to host investor meeting
Subscribe for More Information
06:04 EDTPDSPrecision Drilling divests U.S. coil tubing assets for C$44M
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use